Howard H. Pien

Howard H.
Pien is currently the Chairman at Reckitt Benckiser Pharmaceuticals, Inc. and the Director at Sapience Therapeutics, Inc. He previously held positions such as Chairman, President & Chief Executive Officer at Chiron Corp., Chairman, President & Chief Executive Officer at Medarex, Inc., Non-Executive Chairman at Vanda Pharmaceuticals, Inc., Chairman at Indivior PLC, Non-Executive Chairman at Juno Therapeutics, Inc., Independent Director at ImmunoGen, Inc., Lead Independent Director at Shire ViroPharma, Inc., and President-North American Pharmaceuticals at Smithkline Beecham Plc.
He has also served as a Director at various organizations including Biotechnology Innovation Organization, Ikaria, Inc., Bellerophon Therapeutics, Inc., Talon Therapeutics, Inc., UCSF Benioff Children's Hospital Oakland, The Fox Chase Cancer Center, Pharmaceutical Research & Manufacturers of America, Talon International, Inc., Arresto BioSciences, Inc., SAGE Therapeutics, Inc., Ophirex, Inc., and Abbott Laboratories.
Mr. Pien has an MBA from Carnegie Mellon University and an undergraduate degree from Massachusetts Institute of Technology.